Nanobiotix

(NASDAQ) NBTX

Current Price$35.13

Market Cap$1.74B

Since IPO (2020)+103%

5 Year+139%

1 Year+660%

1 Month-16%

Nanobiotix Financials at a Glance

Market Cap

$1.74B

Revenue (TTM)

€22.45M

Net Income (TTM)

-€92.09M

EPS (TTM)

-$0.57

P/E Ratio

-60.21

Dividend

$0.00

Beta (Volatility)

0.86 (Low)

Dividend

$0.00

Beta (Volatility)

0.86 (Low)

Price

$35.13

Volume

111,961.469

Open

$34.66

Price

$35.13

Volume

111,961.469

Open

$34.66

Previous Close

$35.99

Daily Range

$34.66 - $36.50

52-Week Range

$4.50 - $57.14

Estimated Earnings Date

Sep 30, 2026

Dividend

$0.00

Beta (Volatility)

0.86 (Low)

Price

$35.13

Volume

111,961.469

Open

$34.66

Previous Close

$35.99

Daily Range

$34.66 - $36.50

52-Week Range

$4.50 - $57.14

Estimated Earnings Date

Sep 30, 2026

NBTX News

Getty - happy foursome celebrating victory

Biotech Stock Nanobiotix (NBTX) Is Up 660% This Year -- Here's Why the Rally Could Continue

Selena MaranjianNov 24, 2025

NBTX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nanobiotix

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Laurent Lévy, PhD

Website

www.nanobiotix.com

Headquarters

Paris, 75012, FR

NBTX Financials

Key Financial Metrics (TTM)

Gross Margin

100.00%

Operating Margin

-36.49%

Net Income Margin

-80.83%

Return on Equity

31.23%

Return on Capital

-99.83%

Return on Assets

-35.36%

Earnings Yield

-1.66%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.74B

Shares Outstanding

50.60M

Volume

111.96K

Avg. Volume

77.85K

Financials (TTM)

Gross Profit

€22.45M

Operating Income

-€79.21M

EBITDA

-€79.22M

Operating Cash Flow

-€52.97M

Capital Expenditure

-€1.39M

Free Cash Flow

-€54.37M

Cash & ST Invst.

€52.75M

Total Debt

€95.32M

Nanobiotix Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

€3.01M

-90.9%

Gross Profit

€3.01M

-90.9%

Gross Margin

100.00%

N/A

Market Cap

$1.74B

N/A

Market Cap/Employee

$16.13M

N/A

Employees

108

N/A

Net Income

-€18.58M

-60.1%

EBITDA

-€13.16M

-788.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Total Cash

€52.75M

-29.9%

Total Debt

€95.32M

+88.5%

Accounts Receivable

€7.68M

-19.1%

Inventory

€0.00

N/A

Long Term Debt

€91.01M

+99.8%

Short Term Debt

€4.31M

-14.2%

Return on Assets

-35.36%

N/A

Return on Invested Capital

-1.06%

N/A

Free Cash Flow

-€16.41M

-442.2%

Operating Cash Flow

-€16.01M

-433.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TYRATyra Biosciences, Inc.

TYRATyra Biosciences, Inc.$31.88+3.04%

GHRSGH Research PLC

GHRSGH Research PLC$28.22+11.37%

SVRASavara Inc.

SVRASavara Inc.$5.90-2.16%

EYPTEyePoint Pharmaceuticals, Inc.

EYPTEyePoint Pharmaceuticals, Inc.$13.66-0.36%

KURAKura Oncology, Inc.

KURAKura Oncology, Inc.$10.90+5.21%

ABUSArbutus Biopharma Corp

ABUSArbutus Biopharma Corp$4.58+3.85%

SPRYARS Pharmaceuticals, Inc.

SPRYARS Pharmaceuticals, Inc.$8.54+6.48%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.87+0.02%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$153.23+0.00%

ONDSOndas

ONDSOndas$7.83+0.02%

KEELKeel Infrastructure

KEELKeel Infrastructure$6.03+0.03%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.67+0.04%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$41.31+0.05%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.83-0.04%

Questions About NBTX

What is the current price of Nanobiotix?

Nanobiotix is trading at $35.99 per share.

What is the 52-week range for Nanobiotix?

Over the past 52 weeks, Nanobiotix has traded between $4.50 and $57.14.

How much debt does Nanobiotix have?

As of the most recent reporting period, Nanobiotix reported total debt of €111.95M.

How much cash does Nanobiotix have on hand?

Nanobiotix reported €61.95M in cash and cash equivalents in its most recent financial results.

What is Nanobiotix’s dividend yield?

Nanobiotix does not currently have a dividend yield.

Nanobiotix

Nanobiotix Financials at a Glance

NBTX News

Biotech Stock Nanobiotix (NBTX) Is Up 660% This Year -- Here's Why the Rally Could Continue

NBTX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Nanobiotix

NBTX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Nanobiotix Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NBTX

What is the current price of Nanobiotix?

What is the 52-week range for Nanobiotix?

How much debt does Nanobiotix have?

How much cash does Nanobiotix have on hand?

What is Nanobiotix’s dividend yield?

Premium Investing Services